Unlock stock picks and a broker-level newsfeed that powers Wall Street.

Toronto - Delayed Quote CAD

Profound Medical Corp. (PRN.TO)

Compare
6.61
-0.05
(-0.75%)
At close: 3:59:32 PM EDT

Research Analysis

Earnings Per Share

Consensus EPS
 

Revenue vs. Earnings

Revenue 5.95M
Earnings -7.05M

Q1'24

Q2'24

Q3'24

Q4'24

-10M
-5M
0
5M
 

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
 

Earnings Estimate

Currency in CAD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 4445
Avg. Estimate -0.41-0.39-1.52-0.99
Low Estimate -0.44-0.41-1.68-1.65
High Estimate -0.38-0.37-1.40.14
Year Ago EPS -0.36-0.38-1.6-1.52

Revenue Estimate

Currency in CAD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
No. of Analysts 4445
Avg. Estimate 4.78M5.79M26.05M60.74M
Low Estimate 4.03M5.07M24.61M45.18M
High Estimate 5.75M7.19M27.34M82.13M
Year Ago Sales 2.61M2.01M15.22M26.05M
Sales Growth (year/est) 82.87%188.30%71.18%133.16%

Earnings History

Currency in CAD 3/31/2024 6/30/2024 9/30/2024 12/31/2024
EPS Est. -0.41-0.39-0.42-0.45
EPS Actual -0.36-0.38-0.53-0.29
Difference 0.060.01-0.110.17
Surprise % 13.78%1.31%-26.50%36.98%

EPS Trend

Currency in CAD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Current Estimate -0.41-0.39-1.52-0.99
7 Days Ago -0.38-0.37-1.36-1.04
30 Days Ago -0.4-0.37-1.29-0.86
60 Days Ago -0.4-0.37-1.29-0.86
90 Days Ago -0.4-0.36-1.28-0.85

EPS Revisions

Currency in CAD Current Qtr. (Mar 2025)Next Qtr. (Jun 2025)Current Year (2025)Next Year (2026)
Up Last 7 Days ----32
Up Last 30 Days 1122
Down Last 7 Days 33--1
Down Last 30 Days 2222

Growth Estimates

Current Qtr.Next Qtr.Current YearNext Year
PRN.TO -13.97%-0.75%5.05%34.62%
S&P 500 7.04%5.20%8.89%14.14%

Upgrades & Downgrades

Upgrade Stifel: Hold to Buy 7/16/2024
Maintains Alliance Global Partners: Buy to Buy 3/11/2024
Maintains Stifel: Hold to Hold 3/8/2024
Maintains Alliance Global Partners: Buy to Buy 1/4/2024
Initiated Stifel: Hold 11/28/2023
Downgrade Raymond James: Strong Buy to Outperform 8/4/2023

Related Tickers